(Press-News.org) New guidelines for writing abstracts will help authors summarise their research
A new extension to the PRISMA guideline on reporting systemic reviews and meta-analyses (types of studies that analyse information from many studies) will help authors to give a more robust summary (abstract) of their study and is detailed by an international group of researchers in this week's PLOS Medicine.
These guidelines for abstracts of systemic reviews and meta-analyses are important, as the abstract is the most frequently read part of most papers and these types of studies are particularly important for influencing evidence-based research.
New guidelines are necessary as despite published guidance on writing the abstract in previous guidelines (the PRISMA Statement); evaluations show that reporting of systematic reviews in journal and conference abstracts is poor.
An international group of researchers (the PRISMA for Abstracts Group) developed the new consensus-based reporting guidelines to give authors a checklist and framework for summarising their systematic review into the essentials for an abstract that will meet the needs of many readers.
The authors say: "Abstracts should not replace full articles in informing decision making, but for time-pressed readers and those with limited access to full text reports, the abstract must stand alone in presenting a clear and truthful account of the research."
They continue: "The PRISMA for Abstracts checklist will guide authors in presenting an abstract that facilitates a quick assessment of review validity, an explicit summary of results, facilitates pre-publication or conference selection peer review, and enables efficient perusal of electronic search results."
###
Funding: This research was supported (in part) by the Intramural Research Program of the NIH, National Center for Biotechnology Information (National Library of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: TL is employed by The Cochrane Collaboration. TL is an editor (unpaid) for the Cochrane Airways Group. The authors have declared that no other competing interests exist.
Citation: Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, et al. (2013) PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. PLoS Med 10(4): e1001419. doi:10.1371/journal.pmed.1001419
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001419
Contact:
Elaine Beller
Associate Professor
Bond University
Centre for Research in Evidence-Based Practice
University Drive
Robina, QLD 4229
AUSTRALIA
+61755955523
ebeller@bond.edu.au END
New guidelines for writing abstracts will help authors summarise their research
2013-04-10
ELSE PRESS RELEASES FROM THIS DATE:
Genetic biomarker may help identify neuroblastomas vulnerable to novel class of drugs
2013-04-10
An irregularity within many neuroblastoma cells may indicate whether a neuroblastoma tumor, a difficult-to-treat, early childhood cancer, is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors, Dana-Farber/Children's Hospital Cancer Center scientists will report at the annual meeting of the American Association for Cancer Research in Washington, April 6-10.
The findings (abstract 4622) will be discussed in a minisymposium on Tuesday, April 9, 3:50 - 4:05 p.m., ET, in Room 147, in the Washington Convention Center. The work was published in ...
Alzheimer gene ABCA7 significantly increases late-onset risk among African Americans
2013-04-10
PHILADELPHIA - A variation in the gene ABCA7 causes a twofold increase in the risk of late onset Alzheimer disease among African Americans, according to a meta-analysis by a team of researchers including experts from the Perelman School of Medicine at the University of Pennsylvania. This is the largest analysis to date to determine genetic risk associated with late-onset Alzheimer disease (LOAD) specifically in African American individuals. The study appears in the April 10 issue of JAMA, a genomics theme issue.
The Alzheimer Disease Genetics Consortium (ADGC) – led ...
Modest population-wide weight loss could result in reductions in Type 2 diabetes and cardio disease
2013-04-10
A paper published today on bmj.com suggests a strong association between population-wide weight change and risk of death from type 2 diabetes and cardiovascular disease.
Variation in the prevalence of type 2 diabetes across populations can be largely explained by obesity. However, it is unclear as to what extent weight loss would lower cardiovascular disease prevalence.
Whole population trends in food consumption and transportation policies linked to physical activity could reduce the burden of type 2 diabetes and cardiovascular disease at the population level.
Following ...
Neutrons help explain ozone poisoning and links to thousands of premature deaths each year
2013-04-10
A research team from Birkbeck, University of London, Royal Holloway University and Uppsala University in Sweden, have helped explain how ozone causes severe respiratory problems and thousands of cases of premature death each year by attacking the fatty lining of our lungs.
In a study published in Langmuir, the team used neutrons from the Institut Laue-Langevin in Grenoble and the UK's ISIS Neutron Source to observe how even a relatively low dose of ozone attacks lipid molecules that line the lung's surface. The presence of the lipid molecules is crucial for the exchange ...
TGen-Scottsdale Healthcare clinical trial results for BIND-014 presented at AACR 2013
2013-04-10
WASHINGTON, D.C. — April 9, 2013 — The nanoparticle drug BIND-014 is effective against multiple solid tumors, according to results generated by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, and presented today at the American Association for Cancer Research (AACR) Annual Meeting 2013.
Data for the study was generated at the Virginia G. Piper Cancer Center Clinical Trials, a partnership of TGen and Scottsdale Healthcare.
Dr. Daniel Von Hoff, TGen Physician-In-Chief and Chief Scientific Officer of Scottsdale Healthcare's Clinical Research ...
TGen-Scottsdale Healthcare clinical trial finds new class of cancer drugs safe and effective
2013-04-10
SCOTTSDALE, Ariz. — April 9, 2013 — The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen).
Early results from the phase I, first in-human study of an RNA interface (RNAi) drug were announced during the American Association for Cancer Research (AACR) Annual Meeting 2013, April 6-10, in Washington, D.C. The drug, TKM-080301 (also known as TKM-PLK1) is being developed by Tekmira Pharmaceuticals Corporation.
The ...
The genetics of life and death in an evolutionary arms-race
2013-04-10
Scientists at The University of Manchester have found evidence of the genetic basis of the evolutionary arms-race between parasitoids and their aphid hosts.
The researchers studied the reaction of aphids when a parasitic wasp with genetic variation laid eggs in them. They found that different genotypes of the wasp affected where the aphids went to die, including whether they left the plant host entirely. The team also found an example of the emergence of a shared phenotype that was partly wasp and partly aphid.
Dr Mouhammad Shadi Khudr, a visiting scientist at the Faculty ...
Moa's ark
2013-04-10
Some of the largest female birds in the world were almost twice as big as their male mates. Research carried out by the Zoological Society of London (ZSL) shows that this amazing size difference in giant moa was not due to any specific environmental factors, but evolved simply as a result of scaling-up of smaller differences in male and female body size shown by their smaller-bodied ancestors.
The paper is published today (10th April) in Proceedings of the Royal Society B.
In an environment lacking large mammals, New Zealand's giant moa (Dinornis) evolved to be one ...
Not slippery when wet: Geckos adhere to surfaces submerged underwater
2013-04-10
Geckos are known for their sticky adhesive toes that allow them to stick to, climb on, and run along surfaces in any orientation--even upside down! But until recently, it was not well understood how geckos kept their sticking ability even on wet surfaces, as are common in the tropical regions in which most geckos live. A 2012 study in which geckos slipped on wet glass perplexed scientists trying to unlock the key to gecko adhesion in climates with plentiful rain and moisture.
A study supported by the National Science Foundation and published in the Proceedings of the ...
Dartmouth researchers find there is no single sexy chin
2013-04-10
There is no single sexy chin.
That's the conclusion of a new Dartmouth College global study of male and female preferences for facial characteristics of the opposite sex. The results, which contradict the notion that human beauty is universal, are published in the journal PLOS ONE.
The researchers studied chin shapes among 180 male and female skeletons in nine areas in Australia, Africa, Asia, and Europe to test the universal facial attractiveness hypothesis. The hypothesis proposes that some facial features are universally preferred by the opposite sex because they ...